Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Fernández Mercè

1PUBLICATIONS
5CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Feb 26, 2025
A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer.

Fernández Mercè, Queralt Asla, Francisco J Illana

Pageof 1

Frequent Collaborators

1 joint publications

Queralt Asla

1 joint publications

Francisco J Illana

1 joint publications

Carmela Iglesias

1 joint publications

Susan M Webb

1 joint publications

Anna Aulinas

Frequent Collaborators

1 joint publications

Queralt Asla

1 joint publications

Francisco J Illana

1 joint publications

Carmela Iglesias

1 joint publications

Susan M Webb

Top Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on : Aug 25, 2023

1.1K
See more related videos

Top Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on : Aug 25, 2023

1.1K
See more related videos